| SNM1A-IN-1 |
— |
— |
|
| (3S,6S,9S,12S,15S,18S)-3,6,9,15-Tetrakis(4-aminobutyl)-12-(3-guanidinopropyl)-18-isopropyl-1,4,7,10,13,16-hexaoxo-1-((S)-pyrrolidin-2-yl)-2,5,8,11,14,17-hexaazanonadecan-19-oic acid |
95088-49-6 |
— |
|
| N,N-Dimethyl-2-((2-oxo-4-(o-tolyl)-2H-chromen-7-yl)oxy)propanamide |
2304621-31-4 |
$16–$1605 |
|
| (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-((7-(diethylamino)-2-oxo-2H-chromen-4-yl)methoxy)-2-(2-(4-isopropylphenoxy)acetamido)-9H-purin-9-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite |
1325717-65-4 |
— |
|
| (2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(4-((2-cyanoethyl)thio)-5-methyl-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite |
1290537-73-3 |
$633–$633 |
|
| (2R,3S,5R)-5-(4-benzamido-5-(octa-1,7-diyn-1-yl)-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite |
1021300-97-9 |
— |
|